ADVFN US – Market Content Editor
-
UnitedHealth Shares Gain After Reaffirming 2025 Earnings Guidance
UnitedHealth Group (NYSE:UNH) shares climbed 2.3% following the healthcare company’s reaffirmation of its 2025 earnings outlook ahead of scheduled investor meetings this week. In an SEC filing, the company noted that senior executives will meet with investors and analysts between September 8-10 to review their financial guidance, confirming the adjusted earnings-per-share expectations initially announced on…
-
Chewy Shows Steady Customer Expansion, Hopes for Margin Improvement
Mizuho raised its rating on U.S. online pet retailer Chewy (NYSE:CHWY) to Outperform and increased the price target to $50, citing steady growth in its customer base and early signs that margin pressures are easing. Chewy is scheduled to release quarterly results on Wednesday. Shares rose 2.5% to $43 in premarket trading on Monday. The…
-
QuantumScape Shares Jump 19% Following Live Solid-State Battery Demo on Ducati Motorcycle
QuantumScape (NYSE:QS) stock surged 19% after the company, alongside PowerCo—the battery division of Volkswagen Group—showcased the world’s first real-time demonstration of solid-state lithium-metal batteries powering an electric vehicle at IAA Mobility in Munich. The event featured a modified Ducati V21L racing motorcycle outfitted with QSE-5 battery cells manufactured via QuantumScape’s Cobra production process. This demonstration…
-
Forward Industries Secures $1.65B to Launch Solana-Focused Digital Treasury with Support from Galaxy, Jump, and Multicoin
Forward Industries (NASDAQ:FORD) has completed a $1.65 billion private placement, including both cash and stablecoin commitments, through a private investment in public equity (PIPE) round led by Galaxy Digital, Jump Crypto, and Multicoin Capital. Existing investor C/M Capital Partners also took part in the transaction, marking one of the largest capital raises focused on the…
-
Dow Jones, S&P, Nasdaq, Wall Street Futures Edge Up Ahead of Inflation Reports
U.S. stock futures indicate a modestly higher open on Monday as investors weigh last week’s mixed market performance and weaker-than-expected payroll figures. Despite pulling back from intraday lows on Friday, the major indexes still closed slightly lower. Friday’s Labor Department report showed U.S. nonfarm payrolls rose just 22,000 in August, well below economists’ forecast of…
-
Regeneron Reports Positive Phase 3 Results, Boosting Allergy Treatment Pipeline
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that its first-in-class antibody-blocker therapies for cat and birch allergies have achieved positive outcomes in two Phase 3 clinical trials. The company confirmed that both trials met their primary and secondary endpoints, demonstrating strong efficacy in reducing allergic responses. The combination therapy was well-tolerated, with no serious adverse events reported…
-
Dianthus Therapeutics Shares Jump After Promising Phase 2 gMG Trial Results
Shares of Dianthus Therapeutics (NASDAQ:DNTH) soared 65% following the release of positive results from its Phase 2 trial of claseprubart, an experimental therapy for generalized Myasthenia Gravis (gMG). The company reported that both 300mg and 600mg doses of claseprubart, administered every two weeks, achieved statistically significant and clinically meaningful improvements in key efficacy measures. Patients…
-
Ideaya Biosciences Shares Climb Following Strong Early Lung Cancer Trial Data
Shares of Ideaya Biosciences (NASDAQ:IDYA) surged 10% in premarket trading Monday after the company reported promising preliminary results from an early-stage study of its lung cancer treatment. The Phase 1 trial assessed IDE849 (SHR-4849), developed in collaboration with Hengrui Pharma, for patients with small cell lung cancer. Initial findings indicated an overall response rate of…
-
Summit Therapeutics Shares Plunge After Lung Cancer Drug Data Disappoints
Summit Therapeutics (NASDAQ:SMMT) saw its stock drop 23% in premarket trading after the company released updated longer-term follow-up data from its global trial of the investigational lung cancer therapy, ivonescimab. The new data failed to replicate the promising results previously observed in Chinese studies, raising concerns among investors and analysts. Findings indicated potential overall survival…
-
Premier Shares Jump Amid Rumors of Patient Square Capital Acquisition Talks
Shares of Premier Inc (NASDAQ:PINC) climbed more than 8% in premarket trading on Monday after a Bloomberg News report suggested that Patient Square Capital is exploring a potential acquisition of the healthcare services company. The report, released Friday, cited sources familiar with the discussions, noting that negotiations are still in the early stages. There is…